Cardiorenal Outcomes Among Patients With Atrial Fibrillation Treated With Oral Anticoagulants

Overview of attention for article published in American Journal of Kidney Diseases, October 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news: 7 news outlets
blogs: 3 blogs

twitter: 73 X users

Citations

dimensions_citation: 13 Dimensions

Readers on

mendeley: 23 Mendeley

Summary News Blogs X Dimensions citations

So far, Altmetric has seen 3 posts from 3 blogs.

Highlights from the March 2023 Issue

AJKD Blog, 28 Feb 2023

Editor’s Note: We asked authors of Original Investigations to provide short plain-language summaries that would briefly…

Study Finds Reduced Kidney Disease Progression with DOACs vs Vitamin K Antagonists

MedicalResearch.com, 06 Oct 2022

These findings add to emerging evidence on the safety and effectiveness of DOAC administered for atrial fibrillation.

DOAC use associated with lower risk of kidney complications in patients with atrial fibrillation

news-medical.net, 06 Oct 2022

Swedish cohort study shows 13% (95% CI, 2-22%) lower risk of kidney function decline or kidney failure and 12% (95% CI, 3-20%…

This page shows the most recent blog posts that mention this research output.

Click here to find out how to access more activity.